| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2019-10-31 |
详情>>
股本变动：
变动后总股本71171.45万股
|
| 2019-10-31 |
财报披露：
美东时间 2019-10-31 盘前发布财报
|
| 2019-10-31 |
详情>>
业绩披露：
2019年三季报(累计)每股收益6.81美元,归母净利润48.07亿美元,同比去年增长61.69%
|
| 2019-07-30 |
详情>>
业绩披露：
2019年中报每股收益4.42美元,归母净利润31.16亿美元,同比去年增长64.78%
|
| 2019-04-25 |
详情>>
业绩披露：
2019年一季报每股收益2.20美元,归母净利润15.45亿美元,同比去年增长82.62%
|
| 2019-02-26 |
详情>>
业绩披露：
2016年年报每股收益2.57美元,归母净利润19.99亿美元,同比去年增长24.78%
|
| 2019-02-26 |
详情>>
业绩披露：
2018年年报每股收益5.65美元,归母净利润40.46亿美元,同比去年增长37.62%
|
| 2019-02-22 |
股东大会：
将于2019-04-12召开股东大会
会议内容 ▼▲
- 1.to consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of January 2, 2019, as it may be amended from time to time, which is referred to in this notice as the merger agreement, among Bristol-Myers Squibb Company, a Delaware corporation, which is referred to in this notice as Bristol-Myers Squibb, Burgundy Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Bristol-Myers Squibb, and Celgene, pursuant to which Burgundy Merger Sub, Inc. will be merged with and into Celgene, which is referred to in this notice as the merger, with Celgene surviving the merger as a wholly-owned subsidiary of Bristol-Myers Squibb (a copy of the merger agreement is attached as Annex A to the accompanying joint proxy statement/prospectus);
2.to consider and vote on a proposal to approve the adjournment from time to time of the special meeting of stockholders of Celgene, which is referred to in this notice as the Celgene special meeting, if necessary to solicit additional proxies if there are not sufficient votes to adopt the merger agreement at the time of the Celgene special meeting or any adjournment or postponement thereof;
3.to consider and vote on a proposal to approve, on an advisory (non-binding) basis, the compensation that will or may be paid or provided by Celgene to its named executive officers in connection with the merger.
|
| 2018-10-25 |
详情>>
业绩披露：
2018年三季报(累计)每股收益4.12美元,归母净利润29.73亿美元,同比去年增长-1.59%
|
| 2018-08-07 |
详情>>
内部人交易：
WEILAND JOHN H股份增加5575.00股
|
| 2018-07-26 |
详情>>
业绩披露：
2018年中报每股收益2.58美元,归母净利润18.91亿美元,同比去年增长-5.54%
|
| 2018-05-04 |
详情>>
业绩披露：
2018年一季报每股收益1.13美元,归母净利润8.46亿美元,同比去年增长-9.23%
|
| 2018-04-30 |
股东大会：
将于2018-06-13召开股东大会
会议内容 ▼▲
- 1.to elect twelve directors;
2.to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.to hold an advisory vote on our 2017 named executive officer compensation;
4.to consider a stockholder proposal, if properly presented, described in more detail in the proxy statement;
5.to consider a stockholder proposal, if properly presented, described in more detail in the proxy statement;
6.to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2018-02-07 |
详情>>
业绩披露：
2017年年报每股收益3.77美元,归母净利润29.40亿美元,同比去年增长47.07%
|
| 2017-10-26 |
详情>>
业绩披露：
2017年三季报(累计)每股收益3.87美元,归母净利润30.21亿美元,同比去年增长92.42%
|
| 2017-10-20 |
复牌提示：
2017-10-19 16:29:23 停牌，复牌日期 2017-10-19 17:00:00
|
| 2017-04-27 |
股东大会：
将于2017-06-14召开股东大会
会议内容 ▼▲
- 1.to elect eleven directors;
2.to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.to approve an amendment and restatement of our 2008 Stock Incentive Plan;
4.to hold an advisory vote on our 2016 named executive officer compensation;
5.to hold an advisory vote on the frequency of the advisory vote on executive compensation;
6.to consider a stockholder proposal, if properly presented, described in more detail in the proxy statement;
7.to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2016-04-28 |
股东大会：
将于2016-06-15召开股东大会
会议内容 ▼▲
- 1. to elect twelve directors;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3. to approve an amendment to our 2008 Stock Incentive Plan (amended and restated as of April 15, 2015);
4. to hold an advisory vote on our 2015 named executive officer compensation;
5. to ratify an amendment to the Company’s By-laws;
6. to consider two separate stockholder proposals, if properly presented, described in more detail in the proxy statement;
7. to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2015-04-30 |
股东大会：
将于2015-06-17召开股东大会
会议内容 ▼▲
- 1. to elect nine directors;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
3. to approve an amendment and restatement of our 2008 Stock Incentive Plan;
4. to hold an advisory vote on 2014 named executive officer compensation;
5. to consider a stockholder proposal, if properly presented, described in more detail in the proxy statement;
6. to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2014-06-19 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2014-04-28 |
股东大会：
将于2014-06-18召开股东大会
会议内容 ▼▲
- 1. to elect nine directors;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
3. to vote upon a proposal to amend Article Fourth of the Company’s Certificate of Incorporation, as amended, to increase the authorized number of shares of common stock from 575,000,000 shares, par value of $.01 per share, to 1,150,000,000 shares, par value of $.01 per share, and to effect a split of the issued common stock of the Company by changing each issued share of common stock into two shares of common stock;
4. to approve an amendment of our 2008 Stock Incentive Plan;
5. to hold an advisory vote on 2013 named executive officer compensation;
6. to consider a stockholder proposal, if properly presented, described in more detail in the proxy statement;
7. to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|
| 2013-05-01 |
股东大会：
将于2013-06-12召开股东大会
会议内容 ▼▲
- 1. to elect nine directors;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013;
3. to approve the amendment and restatement of our 2008 Stock Incentive Plan;
4. to hold an advisory vote on 2012 named executive officer compensation;
5. to consider a stockholder proposal described in more detail in the proxy statement;
6. to transact such other business as may properly come before the Annual Meeting and at any adjournment or postponement thereof.
|